Abstract:Introduction: Both the loss of awareness for cognitive decline (a. k.a anosognosia) and neuropsychiatric symptoms (NPS) are common in patients with Alzheimer's disease (AD) dementia, even in prodromal stages, and may exacerbate functional impairment and negatively impact caregiver burden. Despite the high impact of these symptoms on patients and their caregivers, our knowledge of how they develop across the AD spectrum is limited. Here, we explored the cross-sectional and longitudinal associations between anosognosia and NPS in individuals with mild cognitive impairment (MCI). Methods: We included 237 participants from the Alzheimer's Disease Neuroimaging Initiative (ADNI) with a baseline clinical diagnosis of MCI. Everyday Cognition (ECog) questionnaire scores were used to measure complaints from participants and study-partners at baseline and annually over a mean of 4.29 years [standard deviation (SD) = 2.72]. Anosognosia was defined as the study-partner having an ECog score ≥2.5/4 and the participant having an ECog score <2.5/4 on their baseline measure and their last observation without more than two consecutive deviating observations during the follow-up period. The 12-item study-partner-rated Neuropsychiatric Inventory determined the presence or absence of specific NPS. Survival analyses were performed to analyze the frequency and temporal onset of NPS over time in individuals with and without anosognosia. Results: Thirty-eight out of 237 participants displayed anosognosia. Groups had similar lengths of follow-up at baseline ( p > 0.9), though participants with anosognosia had lower MMSE scores ( p = 0.049) and a higher proportion of amyloid-positivity using PET ( p < 0.001. At baseline, the frequencies of agitation ( p = 0.029 ) and disinhibition ( p < 0.001 ) were higher in the anosognosia group compared to the non-anosognosia group. Survival analyses showed earlier onset of seven of the 12 NPS in the anosognosia group (p's < 0.001). Discussion: Loss of awareness for cognitive decline is associated with greater frequency and earlier onset of NPS over time in participants with MCI. These results support the hypothesis of a potential common underlying neurophysiological process for anosognosia and NPS, a finding that needs to be addressed in future studies.

Influence of Anosognosia on Patient-Reported Outcomes for Psychiatric Symptoms and Quality of Life in Huntington's Disease

Structural MRI Correlates of Anosognosia in Huntington's Disease

Perceived Effects of Neuropsychiatric Symptoms on Functional Status in Early-stage Huntington Disease

Mental health symptoms among those affected by Huntington's disease: A cross-sectional study

Effects of Anosognosia on Static and Dynamic Amplitudes of Low-Frequency Fluctuation in Mild Cognitive Impairment

Anosognosia is associated with increased prevalence and faster development of neuropsychiatric symptoms in mild cognitive impairment

Impaired Self-Awareness in Parkinson's and Huntington's Diseases: A Literature Review of Neuroimaging Correlates

Subjective cognitive function in hoarding disorder

The early years: hirschsprung disease and health-related quality of life

On the association between apathy and deficits of social cognition and executive functions in Huntington's disease

Meaning and purpose in Huntington's disease: a longitudinal study of its impact on quality of life

Psychiatric predictors of quality of life in Parkinson's disease: A three-year longitudinal study

Anosognosia for memory deficits in mild cognitive impairment: Insight into the neural mechanism using functional and molecular imaging

Clinical impairment in premanifest and early Huntington's disease is associated with regionally specific atrophy

Awareness of Self and Disease Assessment: Development and Validation of a Subjective Measure in People with Alzheimer's Disease

The Comprehensive Analysis of Motor and Neuropsychiatric Symptoms in Patients with Huntington's Disease from China: A Cross-Sectional Study.

Emotion recognition and experience in Huntington's disease: Is there a differential impairment?

Association of Baseline Depression and Anxiety with Longitudinal Health Outcomes in Parkinson's Disease

Exploring emotion regulation and emotion recognition in people with presymptomatic Huntington's disease: The role of emotional awareness

Abstract TP103: Association Between Neighborhood-Level Disadvantage and Patient-Reported Mental Health Outcomes in Intracerebral Hemorrhage Survivors

Apathy and Impulsivity Co‐Occur in Huntington's Disease